Skip to main content
Filing year 2024

Progressive Familial Intrahepatic Cholestasis

Stanton, Kentucky·EIN 83-1084501·NTEE G01 · Diseases, Disorders & Medical Disciplines·501(c)(3)
Total revenue
$352k
Total assets
$213k
Total expenses
$502k
Reported officers
7
Mission

To improve the lives of patients and families worldwide affected by Progressive Familial Intrahepatic Cholestasis, PFIC.

Executive compensation

Form 990 · Part VII & Schedule J · 1 reported individual · Filing year 2024

Percentile bands compare each position's total pay with the same role at Diseases, Disorders & Medical Disciplines organizations nationwide.

Co-founder Executive Director
25th percentile to median
$71k
$75k

Teal figures restate each filed amount in 2026 dollars.

Estimated with BLS CPI-U for the South region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 6 unpaid individuals.

Browse compensation in Diseases, Disorders & Medical Disciplines

Pay in context

Top pay as a share of expenses

In 2024, the highest total compensation at Progressive Familial Intrahepatic Cholestasis equaled 14% of the organization's total expenses. The median for diseases, disorders & medical disciplines organizations is 10%.

This organization (2024)
14%
Sector median
10%
Middle half of sector
4% to 22%

Based on 2,393 diseases, disorders & medical disciplines organizations, each measured at its most recent filing year with reported expenses and compensation.

Held steady
from 2023

From $71k in 2023 to $71k in 2024.

$71k
2023
$71k
2024
In today's dollarsEst.
Down 3% in real terms$78k to $75k

Estimated with BLS CPI-U for the South region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

FAQ

Common questions about Progressive Familial Intrahepatic Cholestasis

What does the Chief Executive Officer of Progressive Familial Intrahepatic Cholestasis earn?

In 2024, the Chief Executive Officer of Progressive Familial Intrahepatic Cholestasis received $71,000 in total compensation. This pay is below the median (the midpoint) for Chief Executive Officer roles among Diseases, Disorders & Medical Disciplines organizations nationwide, but above the bottom quarter of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at Progressive Familial Intrahepatic Cholestasis compare with similar nonprofits?

Compared with the same role at Diseases, Disorders & Medical Disciplines organizations nationwide, the 2024 pay of the Chief Executive Officer at Progressive Familial Intrahepatic Cholestasis falls between the 25th percentile and the median. In 2024, the highest total compensation at Progressive Familial Intrahepatic Cholestasis equaled 14% of the organization's total expenses. The median for diseases, disorders & medical disciplines organizations is 10%.

What are Progressive Familial Intrahepatic Cholestasis's revenue and expenses?

In 2024, Progressive Familial Intrahepatic Cholestasis reported $352k in total revenue and $502k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.